Clinical trial
A Phase I Dose Escalation Study of Harmine in Healthy Subjects
NCT05526430 is registered in ClinicalTrials.gov with James Murrough as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Phase I Dose Escalation Study of Harmine in Healthy Subjects
- Lead sponsor
- James Murrough
- Phase
- Phase 1
- Overall status
- Completed
- Start date
- September 13, 2022
- Completion date
- June 23, 2023
- Enrollment
- 27 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.